← All funded startups

May 15, 2026

Silexion Therapeutics

Silexion Therapeutics priced a new warrants exercise deal at $0.50 to raise $1 million, issuing new Series C and Series D warrants.

Round
Series D
Amount raised
$1M
Lead investor
Industry
Biotechnology
Headquarters
Ramat Gan, Israel
Employees

Source: Google Alerts